Neuralink is a neurotechnology company focused on developing brain-computer interfaces to restore autonomy for people with unmet medical needs and to advance human potential. The organization conducts research and development in neural interfaces, aiming to treat neurological conditions and enable new forms of human-machine interaction. Its work is positioned as global in scope, with emphasis on medical applications for paralysis and related impairments. The company communicates a long-term mission of redefining human capabilities through advanced neural implants.
No Keynotes, No BS — Why This Year’s Best Tech Talks Happened over Cocktails at StrictlyVC
The Future Will Be Explained to You in Palo Alto
OpenAI Invests in Sam Altman’s Brain Computer Interface Startup Merge Labs
Edward ‘Big Balls’ Coristine Is Helping Out on Viral Fraud Videos Now
Registration Opens for Robotics Summit & Expo 2026
Beyond the Chatbot: Why the Future of AI Needs to See What You See
Bidirectionality Is the Obvious BCI Paradigm
The New Gold Rush in Brain Science
China’s Brain-Computer Interface Industry Is Racing Ahead
Bye-Bye Corporate Conglomerates. Hello Personal Conglomerates.
Will 2026 See a ‘ChatGPT Moment’ for Microchip Implants?
‘Warcraft… with Pure Thought Control’ — 100 Days with Neuralink ‘Feels Like Science Fiction’ to Early Brain Chip Pioneer
Weekly Reads: Organoids ‘Pregnant’ with Human Embryos, Neuralink, Biotech Scorecard, Iffy Autism Tests
Epia Neuro Unveils Brain Implant to Restore Hand Function in Stroke Survivors
Energy, Healthcare and Utilities: How to Tap Into AI in the Real Economy
A New Implant Aims to Rewire the Brain to Help Stroke Patients
Sequoia Partner Spreads Debunked Brown Shooting Theory, Testing New Leadership
San Francisco–Based Venture University Launches UK Investor Accelerator
China Is Moving Faster on Next-Gen Tech. The U.S. Is Trying to Keep Up
No recent deals for this company.